When the window opens, be prepared.

We are biotech’s integrated resource for IPO preparation and execution.

Our extensive knowledge, connections and experience in the financing paths for life science companies can be the difference maker in a well-planned, well-executed raise. Whether a crossover round, IPO or reverse merger, we provide strategic and operational leadership in an efficient, fractional way, including skill sets to supplement your internal resources or to act as your full finance and IR function throughout the process and beyond.